Arjo (A39) Stock Overview
Develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
A39 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Arjo AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.52 |
| 52 Week High | SEK 3.56 |
| 52 Week Low | SEK 2.41 |
| Beta | 0.78 |
| 1 Month Change | -11.39% |
| 3 Month Change | -9.87% |
| 1 Year Change | -28.93% |
| 3 Year Change | -29.53% |
| 5 Year Change | -57.82% |
| Change since IPO | 27.27% |
Recent News & Updates
Recent updates
Shareholder Returns
| A39 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 1.1% | 3.5% | 1.6% |
| 1Y | -28.9% | -24.5% | 7.9% |
Return vs Industry: A39 underperformed the German Medical Equipment industry which returned -24.5% over the past year.
Return vs Market: A39 underperformed the German Market which returned 7.9% over the past year.
Price Volatility
| A39 volatility | |
|---|---|
| A39 Average Weekly Movement | 4.2% |
| Medical Equipment Industry Average Movement | 5.6% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in DE Market | 14.0% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: A39 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: A39's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1957 | 7,000 | Andreas Elgaard | www.arjo.com |
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia care, bariatric room solutions, prone positioning, early mobility, architects and planners, and rehabilitation services, as well as equipment repair and maintenance, and equipment rental and financing solutions.
Arjo AB (publ) Fundamentals Summary
| A39 fundamental statistics | |
|---|---|
| Market cap | €699.74m |
| Earnings (TTM) | €31.32m |
| Revenue (TTM) | €1.03b |
Is A39 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A39 income statement (TTM) | |
|---|---|
| Revenue | SEK 11.00b |
| Cost of Revenue | SEK 6.32b |
| Gross Profit | SEK 4.69b |
| Other Expenses | SEK 4.35b |
| Earnings | SEK 334.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 22, 2026
| Earnings per share (EPS) | 1.23 |
| Gross Margin | 42.59% |
| Net Profit Margin | 3.04% |
| Debt/Equity Ratio | 55.3% |
How did A39 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/22 21:52 |
| End of Day Share Price | 2026/02/20 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Arjo AB (publ) is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| null null | ABG Sundal Collier |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |
| Erik Cassel | Danske Bank |